K201441

Substantially Equivalent

Elecsys Troponin T Gen 5

Applicant: Roche Diagnostics
Product code: MMI
Advisory panel: Clinical Chemistry
Date received: 2020-06-01
Decision date: 2021-09-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Adverse events under product code MMI

product code MMI

Injury: 172
Malfunction: 3,762
Total: 3,934

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.